Cardlytics, Inc. (CDLX) stock
Close on Nov 13, 2026Market cap $7.89MP/E –Yield –
Earnings
Cardlytics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Cardlytics's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 3, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 5, 2026after the close | $32.90M | -36.7% | -$1.26 | -$1.03 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 5, 2026after the close | $36.90M | -41.6% | -$1.50 | -$0.81 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 7, 2026after the close | $34.30M | -44.6% | -$0.08 | -$0.11 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 4, 2026after the close | $56.10M | -24.2% | -$0.15 | $0.03 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 5, 2025after the close | $52.00M | -22.5% | -$1.36 | -$0.07 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 6, 2025after the close | $63.20M | -9.2% | -$0.18 | -$0.13 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 7, 2025after the close | $61.90M | -8.4% | -$0.26 | -$0.21 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 12, 2025after the close | $74.00M | -17.0% | -$0.31 | $0.00 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 6, 2024after the close | $67.10M | -15.1% | -$2.90 | -$0.15 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 7, 2024after the close | $69.60M | -9.3% | -$0.09 | -$0.15 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 8, 2024after the close | $67.60M | – | -$0.56 | -$0.09 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 14, 2024after the close | $89.20M | +8.1% | -$2.56 | $0.14 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 8, 2023after the close | $79.00M | +8.7% | -$0.63 | $0.01 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 1, 2023after the close | $76.70M | +1.7% | -$0.67 | -$0.24 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 4, 2023before the open | – | – | – | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 1, 2023after the close | $82.50M | -8.3% | -$11.32 | -$0.29 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 1, 2022after the close | $72.70M | +11.8% | $0.19 | -$0.50 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 2, 2022after the close | $75.40M | – | -$3.75 | -$0.65 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 2, 2022after the close | $67.90M | – | $0.91 | -$0.38 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 1, 2022after the close | $90.00M | – | -$0.35 | -$0.15 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 2, 2021after the close | $65.00M | – | -$1.35 | -$0.33 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 3, 2021after the close | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 4, 2021after the close | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Mar 1, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 2, 2020after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Cardlytics's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| RevenueGAAP | Q4 FY2026 | $35.00M – $39.00M | – | New | Nov 5, 2026 |
| Adjusted EBITDAnon-GAAP | Q4 FY2026 | -$1.00M – $2.00M | – | New | Nov 5, 2026 |
| Adjusted Contributionnon-GAAP | Q4 FY2026 | $20.00M – $23.00M | – | Lowered | Nov 5, 2026 |
| Billingsnon-GAAP | Q4 FY2026 | $63.00M – $69.00M | – | New | Nov 5, 2026 |
Guidance vs results
The last range Cardlytics gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q2 FY2026 | Revenue | $35.00M – $40.00M | $36.90M | Within range |
| Q2 FY2026 | Revenue growth | -40% – -31% | -41.61% | Below range |
| Q1 FY2026 | Revenue | $35.00M – $40.00M | $34.30M | Below range |
| Q4 FY2025 | Revenue | $51.10M – $59.10M | $56.10M | Within range |
| Q3 FY2025 | Revenue | $52.20M – $58.20M | $52.00M | Below range |
| Q1 FY2025 | Revenue | $57.00M – $60.00M | $61.90M | Above range |
| Q3 FY2024 | Revenue | $56.00M – $63.00M | $67.10M | Above range |
| Q2 FY2024 | Revenue | $73.00M – $81.00M | $69.60M | Below range |
| Q1 FY2024 | Revenue | $70.00M – $73.00M | $67.60M | Below range |
| Q4 FY2023 | Revenue | $82.00M – $90.00M | $89.20M | Within range |
| Q3 FY2023 | Revenue | $75.00M – $84.00M | $79.00M | Within range |
| Q4 FY2022 | Revenue | $80.00M – $90.00M | $82.50M | Within range |
| Q2 FY2022 | Revenue | $73.00M – $80.00M | $75.40M | Within range |
| Q4 FY2021 | Revenue | $70.00M – $80.00M | $90.00M | Above range |
Guidance history
Every forecast Cardlytics put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 5, 2026 | Adjusted EBITDA | Q4 FY2026 | -$1.00M – $2.00M | New |
| Nov 5, 2026 | Billings | Q4 FY2026 | $63.00M – $69.00M | New |
| Nov 5, 2026 | Adjusted Contribution | Q4 FY2026 | $20.00M – $23.00M | Lowered |
| Nov 5, 2026 | Revenue | Q4 FY2026 | $35.00M – $39.00M | New |
| May 7, 2026 | Adjusted EBITDA | Q2 FY2026 | -$2.70M – $1.30M | New |
| May 7, 2026 | Adjusted EBITDA YoY Change | Q2 FY2026 | -$5.70M – -$1.70M | Lowered |
| May 7, 2026 | Billings YoY Change | Q2 FY2026 | -38% – -32% | New |
| May 7, 2026 | Adjusted Contribution YoY Change | Q2 FY2026 | -36% – -27% | Raised |
| May 7, 2026 | Billings | Q2 FY2026 | $61.00M – $67.00M | New |
| May 7, 2026 | Adjusted Contribution | Q2 FY2026 | $20.00M – $23.00M | Lowered |
| May 7, 2026 | Revenue YoY Change | Q2 FY2026 | -40% – -31% | New |
| May 7, 2026 | Revenue | Q2 FY2026 | $35.00M – $40.00M | New |
| Mar 4, 2026 | Adjusted EBITDA | Q1 FY2026 | -$7.50M – -$3.50M | New |
| Mar 4, 2026 | Billings | Q1 FY2026 | $57.50M – $63.50M | New |
| Mar 4, 2026 | Adjusted Contribution | Q1 FY2026 | $20.00M – $23.00M | Lowered |
| Mar 4, 2026 | Consumer Incentives | Q1 FY2026 | $17.50M – $28.50M | Raised |
| Mar 4, 2026 | Revenue | Q1 FY2026 | $35.00M – $40.00M | New |
| Nov 5, 2025 | Adjusted EBITDA | Q4 FY2025 | $900.00K – $7.90M | New |
| Nov 5, 2025 | Billings | Q4 FY2025 | $86.00M – $96.00M | New |
| Nov 5, 2025 | Adjusted Contribution | Q4 FY2025 | $29.00M – $35.00M | Lowered |
| Nov 5, 2025 | Revenue | Q4 FY2025 | $51.10M – $59.10M | New |
| Aug 6, 2025 | Adjusted EBITDA | Q3 FY2025 | -$2.30M – $2.70M | New |
| Aug 6, 2025 | Billings | Q3 FY2025 | $87.00M – $95.00M | New |
| Aug 6, 2025 | Adjusted Contribution | Q3 FY2025 | $30.30M – $34.30M | Lowered |
| Aug 6, 2025 | Revenue | Q3 FY2025 | $52.20M – $58.20M | New |
| Mar 12, 2025 | Adjusted EBITDA | Q1 FY2025 | -$7.50M – -$4.00M | New |
| Mar 12, 2025 | Billings | Q1 FY2025 | $91.50M – $94.50M | New |
| Mar 12, 2025 | Adjusted Contribution | Q1 FY2025 | $30.00M – $32.50M | Lowered |
| Mar 12, 2025 | Revenue | Q1 FY2025 | $57.00M – $60.00M | New |
| Aug 7, 2024 | Adjusted EBITDA | Q3 FY2024 | -$6.00M – -$3.50M | New |
| Aug 7, 2024 | Billings | Q3 FY2024 | $100.00M – $106.00M | New |
| Aug 7, 2024 | Adjusted Contribution | Q3 FY2024 | $32.00M – $35.00M | Lowered |
| Aug 7, 2024 | Revenue | Q3 FY2024 | $56.00M – $63.00M | New |
| May 8, 2024 | Adjusted EBITDA | Q2 FY2024 | -$3.00M – $1.00M | New |
| May 8, 2024 | Billings | Q2 FY2024 | $115.00M – $126.00M | New |
| May 8, 2024 | Adjusted Contribution | Q2 FY2024 | $40.00M – $45.00M | Lowered |
| May 8, 2024 | Revenue | Q2 FY2024 | $73.00M – $81.00M | New |
| Mar 14, 2024 | Adjusted EBITDA | Q1 FY2024 | -$1.00M – $1.00M | New |
| Mar 14, 2024 | Billings | Q1 FY2024 | $105.00M – $109.00M | New |
| Mar 14, 2024 | Adjusted Contribution | Q1 FY2024 | $37.00M – $39.00M | Lowered |
| Mar 14, 2024 | Revenue | Q1 FY2024 | $70.00M – $73.00M | New |
| Nov 8, 2023 | Adjusted EBITDA | Q4 FY2023 | $4.00M – $8.00M | New |
| Nov 8, 2023 | Billings | Q4 FY2023 | $122.00M – $133.00M | New |
| Nov 8, 2023 | Adjusted contribution | Q4 FY2023 | $44.00M – $50.00M | Lowered |
| Nov 8, 2023 | Revenue | Q4 FY2023 | $82.00M – $90.00M | New |
| Aug 1, 2023 | Adjusted EBITDA | Q3 FY2023 | -$2.00M – $2.00M | New |
| Aug 1, 2023 | Billings | Q3 FY2023 | $111.00M – $123.00M | New |
| Aug 1, 2023 | Adjusted contribution | Q3 FY2023 | $39.00M – $45.00M | Lowered |
| Aug 1, 2023 | Revenue | Q3 FY2023 | $75.00M – $84.00M | New |
| Apr 4, 2023 | Adjusted EBITDA | Q1 FY2023 | -$8.00M – -$5.00M | Raised |
| Apr 4, 2023 | Billings | Q1 FY2023 | $93.00M – $97.00M | Raised |
| Apr 4, 2023 | Adjusted contribution | Q1 FY2023 | $30.00M – $33.00M | Lowered |
| Apr 4, 2023 | Revenue | Q1 FY2023 | $63.50M – $66.50M | Raised |
| Mar 1, 2023 | Adjusted EBITDA | Q1 FY2023 | -$17.00M – -$10.00M | New |
| Mar 1, 2023 | Billings | Q1 FY2023 | $84.00M – $93.00M | New |
| Mar 1, 2023 | Adjusted contribution | Q1 FY2023 | $26.00M – $31.00M | Lowered |
| Mar 1, 2023 | Revenue | Q1 FY2023 | $54.00M – $63.00M | New |
| Nov 1, 2022 | Billings | Q4 FY2022 | $120.00M – $132.00M | New |
| Nov 1, 2022 | Adjusted contribution | Q4 FY2022 | $38.00M – $44.00M | Lowered |
| Nov 1, 2022 | Revenue | Q4 FY2022 | $80.00M – $90.00M | New |
| Aug 2, 2022 | year-over-year growth | FY2022 | +10% – +15% | New |
| May 2, 2022 | Billings | Q2 FY2022 | $106.00M – $116.00M | New |
| May 2, 2022 | Adjusted contribution | Q2 FY2022 | $36.50M – $40.50M | Lowered |
| May 2, 2022 | Revenue | Q2 FY2022 | $73.00M – $80.00M | New |
| Nov 2, 2021 | Billings | Q4 FY2021 | $105.00M – $120.00M | New |
| Nov 2, 2021 | Adjusted contribution | Q4 FY2021 | $33.00M – $38.00M | Lowered |
| Nov 2, 2021 | Billings | FY2021 | $365.10M – $380.10M | New |
| Nov 2, 2021 | Adjusted contribution | FY2021 | $118.60M – $123.60M | Lowered |
| Nov 2, 2021 | Revenue | Q4 FY2021 | $70.00M – $80.00M | New |
| Nov 2, 2021 | Revenue | FY2021 | $247.10M – $257.10M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Cardlytics filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Update
- Results
- Update
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Update
See a number that looks wrong?